BioCentury

3:49 PM GMT, Apr 5, 2018
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Financial News

RA Capital leads Eidos' $64M series B round

Eidos Therapeutics Inc. (San Francisco, Calif.) raised a $64 million series B round led

Read the full 147 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.